Task: Answer the multiple choice question.
Query: Which compound exhibits a -28.957% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
[a] CC(CCc1ccccc1)NC(=O)COC(=O)C1CCC(C(C)(C)C)CC1
[b] Cc1ccc2c(CC(=O)OCc3csc(C)n3)coc2c1
[c] Cc1ccccc1NC(=O)CSc1ccc(-c2cccnc2)nn1
[d] CCN(CC)CCn1c(NS(=O)(=O)c2ccc(C)cc2)nc2ccccc21
Answer: c. Cc1ccccc1NC(=O)CSc1ccc(-c2cccnc2)nn1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccccc1NC(=O)CSc1ccc(-c2cccnc2)nn1
Cc1ccccc1NC(=O)CSc1ccc(-c2cccnc2)nn1
N-(2-methylphenyl)-2-(6-pyridin-3-ylpyridazin-3-yl)sulfanylacetamide